drugset / Trial / NCT01114152

AZD9742 Single and Multiple Ascending Dose Study in Healthy Male and Female Japanese Subjects

NCT01114152

Phase 1 Completed 35 enrolled AstraZeneca
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a Phase I randomized double-blind, placebo-controlled, single and multiple ascending dose study to assess the safety, tolerability and pharmacokinetics of AZD9742 in healthy male and female Japanese subjects

Timeline

Start
2010-04
Primary completion
2010-07
Completion
2010-07

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD9742 Unknown Intravenous

Indications

No indication recorded.